Status:
COMPLETED
A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18-130 years
Brief Summary
DISCOVER CKD is an international observational cohort study in patients with CKD, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a prior...
Detailed Description
DISCOVER CKD is an international observational cohort study in CKD patients, comprising both prospective and retrospective patient cohorts. The study does not attempt to test any specific a priori hyp...
Eligibility Criteria
Inclusion
- For all countries, except Japan: Male or female patients aged 18 years and over. For Japan: Male or female patients aged 20 years and over.
- First documented diagnostic code (eg, International Classification of Diseases-10) of CKD (Stages 3A, 3B, 4, 5, or end stage renal disease) or two measures of eGFR of \<75mL/min/1.73 m\^2 recorded at least 90 days apart on or after 1 January 2008, or a code for chronic Renal replacement therapy (hemodialysis and peritoneal dialysis), whichever comes first.
- Provision of written informed consent - specific for prospective data capture.
Exclusion
- Concurrent participation in any interventional trial at baseline (index) (prospective only). To be implemented based on local regulatory requirements.
- The patient is undergoing treatment for active cancer, except for non-melanoma skin cancer.
- Patients with a life expectancy of less than 12 months (prospective only).
- Diagnosis of cancer on or within the 1-year prior to index (retrospective only).
- Less than 1-year registration/medical history (pre-index) (retrospective only).
Key Trial Info
Start Date :
September 11 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
1052 Patients enrolled
Trial Details
Trial ID
NCT04034992
Start Date
September 11 2019
End Date
June 30 2023
Last Update
March 6 2024
Active Locations (43)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Riverside, California, United States, 92505-3071
2
Research Site
San Francisco, California, United States, 94110-3518
3
Research Site
Sanford, Florida, United States, 32771
4
Research Site
Sebring, Florida, United States, 33870-1216